Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Fostering adherence to injectable disease-modifying therapies in multiple sclerosis.
Pathophysiology of immune-mediated demyelinating neuropathies - Part I: Neuroscience.
Multiple sclerosis: Creating a STIR-MRI sequence improves detection of spinal cord lesions.
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review.
Study of fatigue frequency and its association with sociodemographic and clinical variables in patients with multiple sclerosis.
Reducing clinical trial risk in multiple sclerosis.
Endocannabinoids and Endocannabinoid-Related Mediators: Targets, Metabolism and Role In Neurological Disorders.
Epidemiology of neurologically disabling disorders.
Your client has multiple sclerosis: understanding the challenge.
Longitudinally Extensive Varicella-Zoster Virus Myelitis in a Multiple Sclerosis Patient.
Protective effect of cytosolic phospholipase A2 inhibition against inflammation and degeneration by promoting regulatory T cells in rats with experimental autoimmune encephalomyelitis.
Expression, Regulation and Function of MicroRNAs in Multiple Sclerosis.
Neuropathology of multiple system atrophy: New thoughts about pathogenesis.
Caruifolin D from artemisia absinthium L. inhibits neuroinflammation via reactive oxygen species-dependent c-jun N-terminal kinase and protein kinase c/NF-κB signaling pathways.
The Morphofunctional Effect of the Transplantation of Bone Marrow Stromal Cells and Predegenerated Peripheral Nerve in Chronic Paraplegic Rat Model via Spinal Cord Transection.
Treatment with tanshinone IIA suppresses disruption of the blood-brain barrier and reduces expression of adhesion molecules and chemokines in experimental autoimmune encephalomyelitis.
How I treat POEMS syndrome.
Multiple sclerosis: Teriflunomide shows efficacy as an add-on therapy to IFN-β in patients with multiple sclerosis.
Brain connexins in demyelinating diseases: Therapeutic potential of glial targets.
Heterogeneity of cortical lesions in multiple sclerosis: Clinical and pathologic implications.
Multiple sclerosis.
Neutrophils Amplify Autoimmune Central Nervous System Infiltrates by Maturing Local APCs.
Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains?
Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.
Macrophage Migration Inhibitory Factor Potentiates Autoimmune-Mediated Neuroinflammation.
Pages
« first
‹ previous
…
489
490
491
492
493
494
495
496
497
…
next ›
last »